raypeatclips
Member
- Joined
- Jul 8, 2016
- Messages
- 2,555
Nothing new to people on the board but the study is another with reinforces aspirin effectiveness against cancer. The study is about a week old as I post this. How many more studies have to come out before tides change? The study asked people about their aspirin use, and seemed to notice a correlation between aspirin use and less cancer.
Regular Aspirin Use Associates with Lower Risk of Colorectal Cancers With Low Numbers of Tumor-infiltrating Lymphocytes.
Regular Aspirin Use Associates with Lower Risk of Colorectal Cancers With Low Numbers of Tumor-infiltrating Lymphocytes. - PubMed - NCBI
CONCLUSIONS:
Based on data from the prospective cohort studies, regular use of aspirin is associated with a lower risk of colorectal carcinomas with low concentrations of TILs. These findings indicate that the immune response in the tumor microenvironment could be involved in the chemopreventive effects of aspirin.
Regular Aspirin Use Associates with Lower Risk of Colorectal Cancers With Low Numbers of Tumor-infiltrating Lymphocytes.
Regular Aspirin Use Associates with Lower Risk of Colorectal Cancers With Low Numbers of Tumor-infiltrating Lymphocytes. - PubMed - NCBI
CONCLUSIONS:
Based on data from the prospective cohort studies, regular use of aspirin is associated with a lower risk of colorectal carcinomas with low concentrations of TILs. These findings indicate that the immune response in the tumor microenvironment could be involved in the chemopreventive effects of aspirin.
